Showing 19,381 - 19,400 results of 82,552 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( a d decrease ))', query time: 1.56s Refine Results
  1. 19381
  2. 19382
  3. 19383

    miR-34a pull-downs identify novel miR-34a targets involved in cell cycle progression. by Ashish Lal (43926)

    Published 2011
    “…(D) miR-34a represses the 3′UTR of <i>CCND3</i>, <i>MCM2</i>, <i>MCM5</i>, <i>PLK1</i> and <i>SMAD4</i>, but not <i>MCM4</i> and <i>MYT1</i>. …”
  4. 19384
  5. 19385

    Stratified Disk Microrobots with Dynamic Maneuverability and Proton-Activatable Luminescence for <i>in Vivo</i> Imaging by Yuan Liu (88411)

    Published 2021
    “…By leveraging the 3D magnetic gradient fields and the anisotropic composition, the microrobot can be steered to locomote as a gyrating “Euler’s disk”, <i>i</i>.…”
  6. 19386
  7. 19387
  8. 19388
  9. 19389
  10. 19390
  11. 19391

    Supplementary Material for: Surfactant Treatment of Late Preterm Infants during Emergency Transport: A Retrospective, Observational Study by Cavallin F. (11448277)

    Published 2021
    “…Decrease in oxygen concentrations during the transport was larger in neonates receiving surfactant at a referring hospital (adjusted mean difference −11%, 95% confidence interval, −15 to −3%; <i>p</i> = 0.01). …”
  12. 19392
  13. 19393
  14. 19394
  15. 19395
  16. 19396
  17. 19397
  18. 19398
  19. 19399

    Aβ42 peptide accumulation and MAP2 reduction in Tg2576 mouse brains with aging. by Reisuke H. Takahashi (276040)

    Published 2013
    “…(C) Representative images of the SR of the CA1 region of hippocampus demonstrated reduced MAP2 immunoperoxidase staining with aging (2, 9 and 18 months of age) in Tg2576 compared to wild-type mouse brains. Scale bar: 50 µm. (D) Quantification of MAP2-immunoreactivity in the SR of the hippocampal CA1 region revealed an age-related decrease in Tg2576 with aging at 9–11 and 17–18 months compared to at 2–3 months. …”
  20. 19400

    Atg14 plays a cell-intrinsic role in orchestrating eTreg survival but not terminal differentiation. by Erienne G. Norton (9612079)

    Published 2025
    “…<p>(<b>A</b>, <b>B</b>) CD45.2<sup>+ </sup>CD4<sup>+ </sup>Foxp3-YFP<sup>+</sup>CD44<sup>low</sup>CD62L<sup>high</sup> cTregs and CD45.2<sup>+ </sup>CD4<sup>+ </sup>Foxp3-YFP<sup>+</sup>CD44<sup>high</sup>CD62L<sup>low</sup> eTregs were sort-purified from the spleen of control (<i>n</i> =  4) or <i>Foxp3</i><sup>Cre</sup><i>Atg14</i><sup>fl/fl</sup> (<i>n</i> =  3) mixed BM chimera mice and profiled by microarray analysis (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#sec010" target="_blank">Materials and methods</a> for details). …”